Gilead Sciences (GILD) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 11 329 | 8 852 | 10 496 | 4 434 | 13 580 | 13 328 | ||
| Changes by years, y/y, % | +174% | -22% | +19% | -58% | +206% | +26.9% | |||
Gilead Sciences. EBITDA US GAAP, bln rub
Gilead Sciences. EBITDA US GAAP, changes, %
Gilead Sciences. EBITDA US GAAP, sum by quarters, bln rub
Gilead Sciences (GILD) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 2 605 | 3 374 | 4 583 | 3 020 | 3 040 | 13 328 | |
| Changes by years, y/y, % | -174% | +13% | +143% | -3% | +17% | |||
| Changes by quarters, q/q, % | -16% | +30% | +36% | -34% | +1% | |||